Ginsenoside Rb1 Lessens Gastric Precancerous Lesions by Interfering With β-Catenin/TCF4 Interaction

Background: Seeking novel and effective therapies for gastric precancerous lesions (GPL) is crucial to reducing the incidence of gastric cancer. Ginsenoside Rb1 (GRb1) is a major ginsenoside in ginseng and has been proved to possess multiple bioactivities. However, whether GRb1 could protect against...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Jinhao, Ma, Xiao, Zhao, Ziyi, Chen, Yu, Wang, Jundong, Hao, Yanwei, Yu, Junrong, Zeng, Zhongzhen, Chen, Nianzhi, Zhao, Maoyuan, Tang, Jianyuan, Gong, Daoyin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476751/
https://www.ncbi.nlm.nih.gov/pubmed/34594214
http://dx.doi.org/10.3389/fphar.2021.682713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476751/
https://www.ncbi.nlm.nih.gov/pubmed/34594214
http://dx.doi.org/10.3389/fphar.2021.682713

Ejemplares similares